FDA Adds New Warning to GLP-1 Drugs

Watchdoq November 8, 2024
(MedPage Today) -- Labels of all GLP-1 receptor agonists now carry a warning about pulmonary aspiration during general anesthesia or deep sedation.
The warning affects all treatments containing GLP-1 receptor agonists, including semaglutide (Ozempic...

Read Full Article